Trials / Completed
CompletedNCT04804904
A Pharmacokinetic Study of TQB3101 in Chinese Healthy Subjects
A Single Center, Phase I, Open-Label, Randomized, Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of TQB3101 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Evaluate the effect of food on the pharmacokinetics of TQB3101 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TQ-B3101 | TQ-B3101 oral capsule |
Timeline
- Start date
- 2021-05-20
- Primary completion
- 2021-06-15
- Completion
- 2021-07-03
- First posted
- 2021-03-18
- Last updated
- 2022-01-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04804904. Inclusion in this directory is not an endorsement.